Condensed Consolidated Statements of Operations (Unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Operating Expenses:
General and administrative	$ 781,916	$ 1,077,049
Total Operating Expenses	1,138,129	1,415,549
Loss From Operations	(1,138,129)	(1,415,549)
Other (Expense) Income:
Change in fair value of derivative liabilities	5,800
Total Other Expense	(137,277)	(276,018)
Net Loss	(1,275,406)	(1,691,567)
Dividend attributable to Series A, B, and C preferred stockholders	(326,665)	(297,517)
Net Loss Applicable to Common Stockholders	$ (1,602,071)	$ (1,989,084)
Net Loss Per Common Share - Basic	$ (0.04)	$ (0.05)
Net Loss Per Common Share - Diluted	$ (0.04)	$ (0.05)
Weighted Average Common Shares Outstanding - Basic	40,507,352	37,059,766
Weighted Average Common Shares Outstanding - Diluted	40,507,352	37,059,766
Nonrelated Party [Member]
Operating Expenses:
Research and development	$ 341,713	$ 324,000
Other (Expense) Income:
Interest expense	(30,983)	(19,939)
Interest expense - amortization of debt discount	(4,954)	(35,721)
Related Party [Member]
Operating Expenses:
Research and development	14,500	14,500
Other (Expense) Income:
Interest expense	(106,138)	(115,831)
Interest expense - amortization of debt discount	$ (1,002)	$ (104,527)